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Abstract Blood-oxygenation-level-dependent (BOLD)
contrast in magnetic resonance (MR) imaging of skeletal
muscle mainly depends on changes of oxygen saturation in
the microcirculation. In recent years, an increasing number
of studies have evaluated the clinical relevance of skeletal
muscle BOLD MR imaging in vascular diseases, such as
peripheral arterial occlusive disease, diabetes mellitus, and
chronic compartment syndrome. BOLD imaging combines
the advantages of MR imaging, i.e., high spatial resolution,
no exposure to ionizing radiation, with functional infor-
mation of local microvascular perfusion. Due to intrinsic
contrast provoked via changes in hemoglobin oxygen sat-
uration, it is a safe and easy applicable procedure on
standard whole-body MR devices. Therefore, BOLD MR
imaging of skeletal muscle is a potential new diagnostic
tool in the clinical evaluation of vascular, inflammatory,
and muscular pathologies. Our review focuses on the cur-
rent evidence concerning the use of BOLD MR imaging of
skeletal muscle under pathological conditions and high-
lights ways for future clinical and scientific applications.
Keywords Blood-oxygenation-level-dependent MRI 
BOLD effect  Paradigms  Peripheral arterial occlusive
disease  Percutaneous transluminal angioplasty
Introduction
Blood-oxygenation-level-dependent (BOLD) magnetic
resonance imaging (MRI) was introduced in functional
neuroimaging studies in 1990 [1]. Since that time, BOLD
MRI has become the mainstay for analyzing activated
neuronal tissues. Neuronal activation induces changes of
the ratio between oxy- and deoxyhemoglobin concentration
in the local microcirculation [2]. Oxygen saturation influ-
ences T2* signal intensity (SI) in gradient echo MRI
sequences. According to experimental setup and MR
sequence selection, other confounding variables, such as
inflow, blood volume, and extravascular contributions, are
reduced to a large extent. The correlation between T2/T2*
SI and blood oxygen concentration made BOLD MRI the
ideal diagnostic tool for functional neuroanatomical studies
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and clinical applications, such as neurosurgical planning
and monitoring of treatment outcomes.
In the 1990s, BOLD MRI was also evaluated as a
diagnostic tool in other human tissues. Myocardial infarc-
tion has been shown to create a significantly reduced
BOLD response in damaged muscle tissue [3]. The same
study also demonstrated that BOLD SI changes are
reversible after coronary intervention via percutaneous
transluminal angioplasty. Rest and stress-induced BOLD
MRI also differentiated successfully between ischemic,
nonischemic, and normal myocardial segments in a popu-
lation of patients with coronary artery disease [4]. Besides
myocardial pathologies, BOLD MRI is valuable for
investigating physiological blood oxygenation level chan-
ges in the human kidney and uterine myometrium [5, 6]. As
human tumors tissues are often characterized by increased
oxygen consumption leading to hypoxic conditions and
neoangiogenesis, BOLD MRI could also be a valuable tool
for functional tumor imaging. However, in breast and
prostate cancer, BOLD measurements showed heteroge-
neous results with respect to extent of hypoxia prior to
chemotherapy, most likely due to differing tumor neovas-
cularization and stroma tissue [7, 8].
Concerning MRI of the musculoskeletal system, BOLD
MRI has been extensively studied in recent years because
of the easy accessibility of human skeletal muscle to dif-
ferent kinds of imaging paradigms (i.e., exercise- and cuff
compression paradigms that allow generation of ischemic
and hyperemic conditions) and the great variation of per-
fusion strength between resting and activation state. As
BOLD MRI relies on hemoglobin oxygen saturation as
endogenous contrast, one has to provoke changes in the
local ratio of oxy- and deoxyhemoglobin prior to MRI. The
musculoskeletal system permits several different imaging
paradigms to shift the tissue oxygenation level: Oxygen
delivery to skeletal muscle can be increased via increased
oxygen inhalation or vasodilator drugs and decreased via
temporal vascular occlusion or vasoconstrictors. Oxygen
consumption can be increased via muscular exercise. By
using these experimental setups, a large number of studies
has focused on the origin of skeletal muscle BOLD signal
and its physiological dependencies. This information is
helpful for interpreting results of clinical muscle BOLD
MRI studies. As skeletal muscle is the end organ of the
peripheral vascular system, BOLD MRI provides important
information of vascular pathologies, such as peripheral
arterial occlusive disease, diabetes mellitus, and rheumatic
diseases.
In this review, we focus on the clinical implications of
skeletal muscle BOLD MRI. We highlight current evidence
concerning the diagnostic application of functional MRI of
the skeletal muscle and discuss recent and future devel-
opments. After a short overview of the theory behind
skeletal muscle BOLD effect, the technical principles of
the procedure are reviewed in detail with a focus on the
current interpretation of skeletal muscle BOLD signal.
The BOLD effect
Functional MRI is based on the principle that transverse
relaxation rate of water protons inside or in the vicinity of
small blood vessels is influenced by the oxygenation status
of hemoglobin [1]. Oxyhemoglobin concentration in the
microvascular environment of a certain tissue is mainly
influenced by blood flow, intravascular volume, and cap-
illary oxygen extraction. A sole increase of tissue perfusion
with oxygenated hemoglobin at constant levels of oxygen
extraction results in a higher oxy- and lower deoxyhemo-
globin concentration in the local microcirculation and
small venous vessels [9–11]. Deoxyhemoglobin is para-
magnetic and thus causes local magnetic field distortions in
its vicinity. At conditions of increased tissue perfusion, the
lower local deoxyhemoglobin content leads to a decrease
of the apparent transverse relaxation rate (1/T2) of water
protons and an increase of T2 and T2* signal through a
reduced intravoxel spin dephasing (i.e., positive BOLD
contrast) [1, 9]. Due to a phase dispersion of water proton
signals, GRE MRI sequences emphasize this effect [9, 12].
Different physiological parameters have been postulated
to influence skeletal muscle BOLD signal, such as blood
flow, intravascular blood volume, cellular pH and fluid
shifts, vessel diameter, and orientation. However, it is
generally accepted that the bulk of BOLD signal alterations
in GRE sequences of skeletal muscles are due to the oxy-
genation level of hemoglobin [10, 13–21]. Regarding
macro- and microvascular tissue blood flow, good corre-
lations with the muscular BOLD signal have been found in
various studies using different paradigms to provoke
BOLD responses and different techniques for flow mea-
surements such as plethysmography, arterial spin labelling,
and laser Doppler flowmetry [14, 17, 22–24]. The relative
extent of other factors contributing to BOLD contrast
depends on the imaging protocol. Alterations of blood
volume, for example, can lead to changes in T2* signal
[23]. According to a recent study using short isometric
muscle contractions to provoke BOLD SI changes in the
calf muscles, these changes depend on the oxygenation
status of hemoglobin [24]. Thus, if blood oxygen saturation
is at high levels, near 100%, an increase of blood volume in
the leg will cause an increase of T2/T2*, whereas a low
oxygen saturation of about 50% results in a T2* decrease.
Furthermore, two studies found a prolongation of the
BOLD signal increase after increased muscular blood flow
had normalized [25, 26]. This could be explained by
increased oxygen saturation of venous blood and increased
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tissue oxygen tension. Exercise-induced osmotic changes
of the intracellular milieu (i.e., water shift from the circu-
lation to the intracellular space) could also alternate the T2
signal from muscle tissue [27]. However, metabolic chan-
ges during ischemia, such as increasing lactate or phos-
phate concentration or pH-decrease, have been reported to
occur later than usually measured BOLD signal changes
[28]. Additionally, vessel orientation has been proposed to
influence muscle BOLD signal, as most capillaries and
small vessels are oriented along the axis of the muscle
fibers and thus have a determined orientation inside the
static magnetic field [29]. However, a study using a leg
rotation protocol found no influence on BOLD signal in an
arterial occlusion paradigm [15]. Primarily due to sec-
ondary alterations of the variables and mechanisms dis-
cussed above, physiological parameters of the imaged
person such as age, training state, and intake of vasoactive
drugs can have impact on BOLD signal [26, 30–32].
Scientific evidence supports the fact that the BOLD
signal of skeletal muscle is influenced by different factors
which are—to a certain extent—paradigm dependent.
However, using optimized GRE MRI sequences and
experimental conditions, muscle BOLD signal reflects
changes of hemoglobin oxygenation in muscle microves-
sels that primarily depend on perfusion and oxygen con-
sumption. As muscle tissue is the end organ of the limb
vasculature, BOLD MRI is a promising noninvasive
imaging method for functional evaluation of diseases
affecting peripheral macro- and microvasculature. The
following section describes methodological principles that
are usually applied in muscle BOLD studies. Several of
these principals are necessary to measure true BOLD
effects and reduce the influence of confounding
parameters.
Principles of skeletal muscle BOLD MRI
Patient selection
BOLD MRI of skeletal muscle can be a valuable diagnostic
tool under many different clinical conditions that impair
peripheral vasculature and thus result in a reduced oxygen
delivery to skeletal muscle [14, 33–35]. Patients undergo-
ing muscle BOLD imaging therefore usually bear cardio-
vascular risk factors, such as hypertension, smoking,
hypercholesterolemia, diabetes mellitus, and obesity. In
diagnostic studies comprising a patient and control group,
both groups must be controlled for these confounding
variables. Moreover, patient age and training state influ-
ence skeletal muscle BOLD signal [24, 25, 30, 31, 36]. To
date, there is no literature concerning muscle BOLD signal
under inflammatory vascular or skeletal muscle diseases,
but—as an influence on tissue oxygenation and perfusion
cannot ruled out—one should also control for these disor-
ders. Further exclusion criteria for muscle BOLD studies
are typical contraindications of MRI examination, e.g.,
claustrophobia and ferromagnetic implants.
Experimental setup
BOLD MRI of human skeletal muscle is usually performed
in a whole-body MRI device that, in principle, allows
imaging of every muscle within the patient’s body; how-
ever, according to typical clinical questions, routinely, arm
or leg muscles are examined [11, 17, 26, 37]. The extremity
is placed within a vascular array coil, and foam braces can
be used to minimize motion artifacts in exercise paradigms
[22]. Prior to imaging, a resting period of 5–15 min of the
examined individual is required due to the influence of
position changes on the venous filling state and functional
vascular adaptations that have been shown to influence
BOLD SI [23]. To evoke changes in the local hemoglobin
oxygen saturation that correspond to voxel contrastation in
T2/T2* MRI sequences, typically, one of the following
paradigms is applied: (1) arterial occlusion; (2) muscle
exercise; (3) oxygen inhalation.
1. Arterial occlusion has been widely used in a variety of
muscle BOLD studies [10, 11, 13, 14, 23, 30, 38]. It
requires an easily applicable experimental setup with a
standard air cuff wrapped around the proximal part of
the examined extremity (Fig. 1a). If the pressure
manometer contains ferromagnetic parts, a safe dis-
tance from the magnet should be achieved by using an
extended tube [30]. Ischemia is achieved by fast
inflation of the cuff to an occlusion pressure at least
50 mmHg above the individual brachial systolic blood
pressure [14, 30, 33, 36, 38–40]. Extensive arterial
calcification will make higher cuff pressures necessary,
especially in patients with diabetes. Fast inflation is
necessary to prevent immoderate filling of the venous
system. This can be achieved via automatic cuff
inflation systems or fast manual inflation. However,
manual inflation lasts over several cardiac cycles and
thus could lead to increased venous filling. Applied
cuff pressure and duration of ischemic phase is always
a compromise between patient compliance, degree of
discomfort and pain, possible complications, and
assumed optimal muscle BOLD effect (also refer to
‘‘Paradigm selection in clinical settings’’ below). MRI
measurements can be started during resting state,
ischemic phase, or after cuff deflation, i.e., during
reactive hyperemia phase. Besides sustaining suprasy-
stolic cuff compression in the examined leg, this
paradigm is mostly independent from patient
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compliance. However, in patients with critical leg
ischemia or ulcerations, BOLD MRI examination via
cuff compression should be considered with caution
due to massive pain or even worsening of the clinical
condition.
In healthy individuals, a fast T2* signal decay is
observed at the beginning of ischemia, followed by a
slower decrease (Fig. 1b) [13, 14, 38]. During reactive
hyperemia, a fast surge in BOLD signal is observed with
peak values after approximately 30–60 s and a subsequent
decrease to a steady state value around baseline [30, 33].
The extent of BOLD signal changes depends on experi-
mental setup, physiological variables of the examined
patient, and magnetic field strength [11, 13, 17]. To analyze
muscle BOLD data in a quantitative manner, several time-
course parameters can be calculated, including:
• T2min* or MIV: minimal T2* value in percent during
ischemia;
• T2max* or HPV: maximal T2* value during reactive
hyperemia;
• Time to peak (TTP): time from cuff deflation to
hyperemia T2* peaking;
• Declining slope (DS): average decline of T2* curves
during ischemia or reactive hyperemia.
2. As skeletal muscle work results in local increases of
blood flow due to local vasodilation triggered by the
accumulation of metabolites, voluntary contractions of
the imaged individual can be used to provoke a skel-
etal muscle BOLD response. Several studies showed
that brief contractions of about 1–3 s are sufficient to
produce a measurable BOLD response [17, 18, 25].
Motion artifacts are one major drawback in these
studies, so that sophisticated fixation devices or foam
braces need to be installed prior to imaging. Significant
BOLD responses appear 8–15 s after individual mus-
cle contractions [17, 18]. As contraction intensity is
related to BOLD SI changes, this paradigm depends
largely on patient compliance [22].
3. By sequential inhalation of ambient air and 100%
oxygen from a mask with a reservoir, BOLD response
of skeletal muscle can be provoked by repeatedly
increasing and decreasing blood oxygen content (O2-
enhanced MRI) [10]. However, this kind of paradigm
has some drawbacks that constrain its widespread use
in scientific or clinical applications. As oxygen satu-
ration of hemoglobin in healthy young individuals is
near 100%, oxygen ventilation primarily leads to an
increase of dissolved O2 in the blood, whereas the ratio
between oxy- and deoxyhemoglobin does not change
extensively. O2 is paramagnetic and leads to changes
of T1, T2, and T2*. Studies using this paradigm
therefore must be analyzed with care regarding true
BOLD effects that depend on hemoglobin oxygena-
tion. Furthermore, the paradigm has not been exten-
sively evaluated with regard to how large the influence
on true BOLD signal or perfusion is.
Muscle BOLD MRI needs high-speed image acquisition
methods, typically based on echoplanar imaging (EPI)
[41]. Spiral imaging techniques are more prone to image
artifacts due to a higher sensitivity to off-resonance effects
compared with EPI [42]. Water proton susceptibility dif-
ferences depending on oxygen hemoglobin saturation are
emphasized on gradient-echo MRI sequences [1, 12].
BOLD signal alterations of conventional single-shot EPI
are sensitive to changes in T2* and T2—reflecting oxy-
genation—and initial BOLD signal intensity (S0) [30, 33].
S0 is influenced by several confounding parameters, such
as blood inflow, changes in T1, and baseline drifts [16, 43].
Fig. 1 a Experimental setup of the widely used cuff compression
paradigm in skeletal muscle blood-oxygenation-level-dependent
(BOLD) magnetic resonance imaging (MRI). Inflation of a standard
air cuff at midthigh level allows BOLD examination of the calf
microvasculature during ischemia and reactive hyperemia. In T2*
maps calculated from echo planar imaging (EPI) data, regions of
interest (ROIs) are usually positioned at the maximal calf muscle
diameter. Areas with larger vessels are excluded. As T2* images offer
a low spatial resolution, T1-weighted images of the corresponding
calf region are concomitantly acquired for anatomical reference.
b Extracted T2* (BOLD) time course of a healthy 46-year old woman
volunteer with a 60-s resting period, 6 min of ischemia, and 6 min of
reactive hyperemia
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Multiecho GRE EPI sequences with fat suppression can be
used to separate oxygenation-related changes (T2*) from
these other effects [16, 33]. EPIs are superposed to a cor-
responding T1-weighted spin-echo (SE) image of the same
acquisition plane to allow exact placement of the region of
interest (ROI) in a designated muscle (Fig. 1a).
Image analysis
Regarding image analysis, T2* sequences (multiecho acqui-
sition) comprise the highest sensitivity for studying the true
BOLD effect in skeletal muscle. In case of multiecho EPI,
T2* maps are generated by using a pixel-by-pixel least-square
fit of a monoexponential decay to the signal intensities of the
different echo images [14, 30]. T2* values, normalized to a
baseline value set to 100% (i.e., at resting state) can then be
extracted for every examined ROI. Larger vessels should be
excluded to minimize inflow artifacts. A BOLD time course
can be calculated subsequently (Fig. 1b).
Peripheral arterial occlusive disease
Assessment and diagnosis
Peripheral arterial occlusive disease (PAOD) is one of the
leading manifestations of atherosclerosis. Existence of this
disease has a significant impact on the survival of patients
with generalized atherosclerosis [44, 45]. Due to stenoses
and occlusions in the macrovasculature, malperfusion of
the distal tissues (skeletal muscle and skin) occurs [46].
Specifically, in the skeletal muscle, the process of athero-
sclerosis seems to lead to changes in microvessel archi-
tecture and composition of muscle fiber types [47–49].
These factors interact and may significantly reduce oxygen
delivery to and alter oxygen consumption in the skeletal
muscle microcirculation [10].
MR angiography (MRA) detects and localizes stenoses
and occlusions on a macrovascular level but does not allow
a statement about the function of the microvasculature in
the distal tissues [50, 51]. The ankle brachial index (ABI) is
an easily applicable but observer-dependent diagnostic tool
to evaluate the functional status of patients with PAOD [52,
53]. Performing this method is limited when the patient has
incompressible calcified arteries. This is due to a much
larger cuff pressure necessary to compress the vessel under
this condition [54]. PAOD in a patient with arterial calci-
fication thus will not be detected by ABI measurements.
Moreover, there is a lack of noninvasive diagnostic tools to
detect and quantify PAOD disease improvement in terms
of adaption of the vascular system and effectiveness of
vessel stimulation therapies [40, 55]. As previously men-
tioned, BOLD MRI allows conclusions about alterations in
tissue oxygenation of the skeletal muscle, with a high
spatial resolution [19, 43, 56–60]. Thus, it is a potential
diagnostic tool for evaluating microcirculation function in
the skeletal muscle of patients with PAOD.
There are three studies investigating muscle BOLD MRI
in PAOD: Ledermann et al. [33] compared skeletal muscle
BOLD signal of 17 patients with symptomatic PAOD to a
control group consisting of 11 healthy volunteers of similar
age. They performed a T2*-weighted single-shot multiecho
EPI sequence on a whole-body magnetic resonance scanner
at 1.5 T and used an arterial occlusion paradigm with cuff
compression to provoke postischemic reactive hyperemia.
The patient group demonstrated a lower T2max
* and a more
than twofold prolongation of the TTP value. Both differ-
ences were highly significant. Impaired microcirculation in
the human skeletal muscle of the patient group is accom-
panied by a change in the T2* time course. The delayed
TTP might be explained by the lack of oxygenated blood in
the microvasculature, most possibly due to diminished
microperfusion after vascular stenoses. It is difficult to
understand the underlying mechanisms of the significant
T2max
* -decrease. A variety of effects could underly this
mechanism. For instance, the longer contact time of the
blood with the capillaries might lead to a more efficient
deoxygenation of hemoglobin inside the capillaries.
Another factor might be the circulation of a lower blood
volume in patients with PAOD owing to damaged capil-
laries in the skeletal muscle [61, 62]. Further studies cor-
relating BOLD measurements with the assessment of
perfusion (e.g., via laser Doppler flowmetry or arterial spin
labeling) and oxygenation (e.g. via near-infrared spectros-
copy) are warranted to elucidate the exact pathophysio-
logical mechanisms underlying theses BOLD time-course
changes in PAOD patients. An example of a T2* time
course during reactive hyperemia from a patient suffering
from PAOD is shown in Fig. 2a.
Another study investigated muscle BOLD response
during the ischemic phase in 15 patients with PAOD versus
ten healthy volunteers also using a cuff compression par-
adigm [38]. Differences in mean T2min
* values and T2* time
courses were observed between both groups: In the patient
group, a rapid decrease of the T2* time course was fol-
lowed by a slower decrease and finally ending in a constant
T2min
* value that did not change over time. The control
group revealed a rapid decrease of the T2* value during the
entire ischemic period, resulting in a significantly lower
T2min
* compared with the patient group. The observed
differences in the T2* time course are most likely explained
by a reduced oxygen consumption in patients with PAOD,
because T2* decrease was not only diminished but also
retarded when compared with healthy individuals. This
effect may be caused by morphological (i.e., reduced
capillary density) and/or metabolic alterations in the
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skeletal muscle of patients with PAOD, leading to reduced
oxygen consumption in the distal muscle tissue [47, 63]. In
Fig. 2b, an example of a T2* time course during ischemia
from a patient suffering from PAOD is demonstrated.
A study from Versluis et al. [64] deals with reproduc-
ibility of different MRI imaging methods, including muscle
BOLD MRI for assessing patients with PAOD. Postische-
mic reactive hyperemia with a cuff compression paradigm
was provoked in healthy volunteers and PAOD patients and
a multishot single-echo EPI sequence with fat suppression
for acquiring the BOLD response was performed. All
muscles were assessed together with one large ROI over
the entire cross-section of the calf. A poor interscan
reproducibility was determined in this study for the maxi-
mal T2* change [patients: T2max
* = 13.2 ± 6.4%, coeffi-
cient of variation (CV) = 26.7%, repeatability coefficient
(RC) = 9.7%; volunteers: T2max
* = 13.3 ± 5.9%, CV =
21.5%, RC = 7.9%]. However, for the TTP value, fair
reproducibility was demonstrated (patients: TTP = 116 ±
26.8 s, CV = 10.6%, RC = 33.8 s; volunteers: TTP =
60.7 ± 15.9 s, CV = 15.9%, RC = 26.7 s). According to
the authors, tissue oxygenation might change over time.
This can be explained by many intrinsic and extrinsic
factors that influence the day-to-day oxygenation status of
the calf muscle, including but not limited to hormones,
insulin secretion, temperature, day time, and eating habits
[65]. The authors concluded that acquiring reliable func-
tional data with muscle BOLD MRI in patients with
peripheral arterial disease using a 1.5-Tesla MRI scanner is
not advisable in clinical settings, with the exception of the
TTP value. A further cause of the poor interscan repro-
ducibility could be the missing exclusion of larger vessels
from the ROI that included the entire soft tissue of the
analyzed calf diameter. This may have caused inflow
artefacts in the acquired T2* data. Additionally, the used
single-echo EPI sequences makes the BOLD measurement
even more prone to alterations of inflow, T1-, and baseline
changes. Considering these limitations and the fact that
several other published studies evaluating BOLD muscle
MRI in PAOD patients showed significant time course
alterations in relatively small patient collectives, repro-
ducibility of skeletal muscle BOLD MRI could be higher
than evaluated by Versluis et al. [64]. However, due to lack
of supporting evidence, it is necessary to investigate the
reproducibility of muscle BOLD signal in larger studies.
This must inevitable include taking care of maximal stan-
dardization during the imaging procedure and the use of
multiecho sequences to minimize confounding parameters.
In summary, noninvasive diagnosis and follow-up MRI
investigations in patients with PAOD are feasible with
muscle BOLD MRI. By evaluating microcirculation func-
tion in the calf, muscle BOLD MRI has the potential to
serve a noninvasive low-risk (no radiation dose, no contrast
agent) diagnostic tool for monitoring conservative and
invasive therapeutic approaches. Moreover, skeletal muscle
BOLD MRI assesses end-organ function and serves as a
quantitative method for functional imaging in PAOD. In
contrast to other MRI imaging techniques developed with
the same purpose, such as first-pass gadolinium-enhanced
MRI, muscle BOLD MRI does not require any contrast
agent, making repeated measurements possible [66]. With
MRI as a comprehensive diagnostic tool in PAOD, a
macrovascular morphological visualization could be com-
bined with microvascular functional measurements using
muscle BOLD MRI [21, 67, 68]. Such a comprehensive
Fig. 2 a T2* time courses during reactive hyperemia of a 79-year-old
woman suffering from peripheral arterial occlusive disease (PAOD)
with signs of intermittent claudication and restrictions of pain-free
walking distance[200 m (Fontaine Stage IIa, red line) and a 46-year
old healthy woman volunteer (blue line). b T2* time courses during
the ischemic period of a 74-year-old woman suffering from PAOD
with severe claudication and a pain-free walking distance of about
80 m (Fontaine Stage IIb, red line) and the same volunteer as in a
(blue line)
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diagnostic tool might be of high value in clinical settings.
Further investigations in larger patient cohorts are war-
ranted to confirm these encouraging results and to deter-
mine the value of muscle BOLD MRI in clinical settings,
including sensitivity and specificity.
Treatment evaluation
Muscle BOLD MRI has the potential to serve as an objective
tool for planning and assessing the success of different
therapeutic approaches to vascular diseases, such as con-
servative treatment with drugs or invasive procedures such
as stenting or bypass surgery. This is of particular interest
due to the capability of muscle BOLD MRI to reveal end-
organ function rather than global function of macrocircu-
lation [33]. The study by Hu¨gli et al. [40] investigated the
response of muscle BOLD MRI in ten patients with PAOD
1 day before and 6 weeks after percutaneous transluminal
angioplasty of the superficial femoral artery. A cuff com-
pression paradigm was used to provoke reactive hyperemia.
Treatment of stenoses should lead to improved macrovas-
cular and consecutively also microvascular function.
Although not reaching significance level, the investigators
found homogenous improvements of the key BOLD
parameters TTP (decreased), T2max
* (increased), and end
value (decreased) from the first to the second measurement.
The fact that these changes in key BOLD parameters did not
reach significance level was explained by the low number of
patients, the inhomogeneous patient group, and the relative
short follow-up period. Blood inflow over the normal ana-
tomical course of the arteries is faster than over the collateral
vessels. That could be the reason TTP decreased in this
study. T2max
* could have increased due to a diminished
oxygen extraction at higher microcirculatory flow, accord-
ing to the Fick principle. This increase of blood inflow could
also lead to a faster washout of blood from the calf muscle,
thus leading to decreased T2* values at the end of hyperemia.
The increased maximal T2* change might be based on
increased blood oxygen supply. This optimized blood oxy-
gen supply has already been demonstrated with transcuta-
neous oxygen pressure measurements in PAOD patients [69,
70]. New therapeutic concepts in PAOD aim to induce
collateral formation and to improve function of existing
arteries by angiogenic growth factors or stem cell adminis-
tration [71–74]. It might be interesting to see whether muscle
BOLD MRI can demonstrate the success of these approa-
ches by showing improved microcirculatory function.
Compartment syndrome
Chronic compartment syndrome has an unclear underlying
pathophysiology. The main problem seems to be an
exercise-induced increase of tissue pressure in one of the
four compartments of the calf, resulting in a compression
of muscles and vessels [34]. Patients show symptoms
during and after exercise (i.e., walking, cycling) such as
burning, pain, and cramping, which normally resolve under
resting conditions [75]. Most often, the anterior compart-
ment of the calf is affected. The elevated compartment
pressure ([15 mmHg) causes decreased blood inflow,
leading to ischemic pain. To assess chronic pressure effects
in muscle compartments, BOLD signal is an attractive
method to noninvasively detect microvasculature changes.
In a prospective study, Andreisek et al. [39] investigated
muscle BOLD signal alterations in chronic compartment
syndrome patients. They expected a lower T2* signal in
patients with chronic compartment syndrome because of
impaired perfusion and therefore delayed reoxygenation of
the working calf muscle. Nine patients and ten controls
underwent muscle BOLD MRI before and after exercise,
and T2* signal in the lower extremity was registered. An
immediate response after exercise concomitantly with an
increase in T2* in both groups could be demonstrated.
Although the patients reported higher levels of symptoms
during exercise than did controls, a significant difference in
terms of the T2* signal between groups could not be found.
Moreover, the level of pain or muscle weakness did not
show a correlation with the T2* signal. The T2* signal
15 min after muscle exercise was still elevated, which is
most likely not due to a real BOLD effect but rather to
much larger and longer-lasting T2/T2* effects caused by
osmotic changes in muscle after repetitive exercise
[76–78].
Another study used frequency-dependent signal inten-
sity mapping after Fourier transformation to show altera-
tions in BOLD response of a patient with chronic
compartment syndrome [34]. This method relied on the
disappearance of physiological cardiac and respiratory
frequency peaks in the ROIs of the affected compartment.
As spectral SI changes of BOLD signals after Fourier
transformation are absent when excluding visible vessels
from the defined ROIs, this method depends on blood
inflow rather than oxygenation [79]. Hence, a sufficient
imaging paradigm for the diagnosis of chronic compart-
ment syndrome in the clinical setting is still lacking.
Diabetes mellitus
Diabetes mellitus is associated with impaired macro- and
microcirculation [80–82]. Especially in this patient group,
the early diagnosis of disturbances in the vascular system is
crucial to prevent secondary disease complications. Mac-
rovasculature can be visualized with Doppler ultrasound,
MR angiography, or plethysmography [83, 84]. Detecting
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changes of the microvasculature still remains a challenge.
BOLD signal time course and corresponding values reflect
the peripheral microvascular function and thus might be an
interesting diagnostic tool that can be applied in patients
with diabetes mellitus [24, 31]. In a study from Slade et al.
microvascular function was assessed in patients with dia-
betes mellitus types I and II and in a matched control group
using muscle BOLD MRI. An exercise paradigm with
single-muscle contractions was performed. Regarding
BOLD signal of ankle dorsiflexors, no differences were
found between the patients and healthy controls. This was
explained by the relatively short duration of persistent
diabetes in the patient group. In this study, it could be
confirmed that the BOLD response depends significantly
on age. Influence of age on the BOLD signal during
ischemia and reactive hyperemia was already demonstrated
in previous studies using arterial occlusion paradigms [30,
36]. Another BOLD study aimed at detecting blood volume
and oxygenation status in diabetes mellitus type 2 patients
and obese and lean individuals following isometric dorsi-
flexion contractions [85]. A dual GRE EPI sequence with
two different echo times of 6 and 46 ms was applied to
measure MRI signal intensity alterations. The postcon-
traction signal intensity differences were calculated, pre-
dominantly indicating altered blood volume (for TE of
6 ms) or oxygenation status (for TE of 46 ms) [20]. Con-
sidering the echo time of 6 ms, signal intensity differences
were lower in diabetic and obese individuals compared
with the lean group with respect to the extensor digitorum
longus muscle. When evaluating the echo time of 46 ms,
signal intensity differences were only lower in diabetic
patients compared with lean controls. These findings reveal
altered blood volume status in diabetic and obese individ-
uals and altered oxygenation status only in diabetic
patients. These studies show that small-vessel impairment
in patients with diabetes or obesity can be detected with
functional MRI in the absence of overt macro- or micro-
vascular complications. This technique might thus be
helpful for detecting preclinical disease states.
Paradigm selection in clinical settings
Muscle BOLD signal shows a dynamic response to vas-
cular diseases such as PAOD. To induce measurable
changes in the T2* signal, it is necessary to apply a suitable
paradigm. Under resting conditions, patients with vascular
diseases could have a nearly normal oxygenation status in
the calf muscle, but under cuff compression an impaired
microcirculation function is seen because the usual meta-
bolic demand cannot be compensated by a sufficient blood
inflow. All muscle BOLD MRI studies in PAOD patients
used an arterial occlusion paradigm to provoke either
ischemia or reactive hyperemia. This paradigm has some
advantages, particularly when investigating vascular
diseases:
‘1. Blood inflow and outflow can be completely pre-
vented by the suprasystolic pressure.
2. Through fast cuff inflation, the influence of venous
filling on the BOLD signal is minimized.
3. Patient compliance is not required.
4. This paradigm can be standardized for use in clinical
settings.
5. Motion artifacts are a well-known problem in func-
tional MRI of the brain; in the cuff-compression
paradigm, such motion artifacts could be kept to a
minimum.
Points 3 and 5 are particularly relevant advantages of
this paradigm in the clinical setting when compared with
muscle-contraction paradigms. Furthermore, paradigm
selection is a matter of measurable BOLD SI changes.
Regarding patients with diabetes mellitus, oxygenation-
sensitive functional MRI revealed smaller T2 signal
intensity changes than did sequences sensitive for blood
volume [31, 85]. Arterial occlusion paradigms, showing
promising results in PAOD evaluation, have not been tes-
ted in diabetic or obese individuals. For clinical imple-
mentation of skeletal-muscle BOLD MRI, the diagnostic
power of different paradigms should be further evaluated
through mutual analysis. Prior to doing this in patient
collectives, we see the potential to test exercise and arterial
occlusion in older volunteers, where both paradigms suc-
cessfully showed BOLD signal alterations.
As for muscle exercise, arterial occlusion has also some
important drawbacks. A subset of patients complains about
discomfort. In one study, mild to moderate discomfort was
reported [33]. In another study, however, severe discomfort
during cuff inflation was observed in three of eight patients
with PAOD and in three of ten healthy volunteers [64]. In
the third study, all patients tolerated the cuff-compression
paradigm well [40]. Patients with necrosis or gangrene
should be excluded from this paradigm, because suprasy-
stolic cuff compression implies the risk of disease pro-
gression. In patients with bypass surgery, safety concerns
exist regarding the theoretical risk of bypass occlusion
through the suprasystolic cuff pressure.
Conclusion
The authors of this study conclude that muscle BOLD MRI
is a valuable tool to noninvasively assess peripheral
microvasculature. In PAOD, BOLD MRI of skeletal mus-
cle has been proven to successfully differentiate between
patients and healthy individuals. To what extent BOLD
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imaging bears sufficient sensitivity and specificity for
routine clinical implementation is yet to be demonstrated.
Initial reports on other vascular diseases, such as com-
partment syndrome and diabetes, have revealed somewhat
controversial results. This may reflect the need for con-
sistent and efficient experimental muscle BOLD imaging
setups and the use of effective imaging paradigms. How-
ever, several pathological conditions affect the peripheral
vasculature not yet studied by BOLD imaging, i.e., vas-
culitides, connective tissue diseases, and other inflamma-
tory conditions. With well-designed studies, it will be
possible to show under which of these conditions BOLD
MRI of skeletal muscle is helpful in basic research, diag-
nostics, classification, and treatment evaluation. As BOLD
MRI predominantly reflects oxygenation changes in the
microvasculature, new insights into the pathogenesis of
these diseases may be revealed.
References
1. Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic
resonance imaging with contrast dependent on blood oxygena-
tion. Proc Natl Acad Sci USA 87(24):9868–9872
2. Glover GH (2011) Overview of functional magnetic resonance
imaging. Neurosurg Clin N Am 22(2):133–139
3. Wacker CM, Bock M, Hartlep AW, Bauer WR, van Kaick G,
Pfleger S, Ertl G, Schad LR (1999) BOLD-MRI in ten patients
with coronary artery disease: evidence for imaging of capillary
recruitment in myocardium supplied by the stenotic artery. Magn
Reson Mater Phys 8(1):48–54
4. Manka R, Paetsch I, Schnackenburg B, Gebker R, Fleck E,
Jahnke C (2010) BOLD cardiovascular magnetic resonance at 3.0
tesla in myocardial ischemia. J Cardiovasc Magn Reson 12:54
5. Kido A, Koyama T, Kataoka M, Yamamoto A, Saga T, Turner R,
Togashi K (2007) Physiological changes of the human uterine
myometrium during menstrual cycle: preliminary evaluation
using BOLD MR imaging. J Magn Reson Imaging 26(3):695–700
6. Prasad PV, Edelman RR, Epstein FH (1996) Noninvasive eval-
uation of intrarenal oxygenation with BOLD MRI. Circulation
94(12):3271–3275
7. Li SP, Taylor NJ, Makris A, Ah-See ML, Beresford MJ, Stirling
JJ, d’Arcy JA, Collins DJ, Padhani AR (2010) Primary human
breast adenocarcinoma: imaging and histologic correlates of
intrinsic susceptibility-weighted MR imaging before and during
chemotherapy. Radiology 257(3):643–652
8. Alonzi R, Padhani AR, Maxwell RJ, Taylor NJ, Stirling JJ,
Wilson JI, d’Arcy JA, Collins DJ, Saunders MI, Hoskin PJ (2009)
Carbogen breathing increases prostate cancer oxygenation: a
translational MRI study in murine xenografts and humans. Br J
Cancer 100(4):644–648
9. Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann
JM, Ugurbil K (1993) Functional brain mapping by blood oxy-
genation level-dependent contrast magnetic resonance imaging.
A comparison of signal characteristics with a biophysical model.
Biophys J 64(3):803–812
10. Noseworthy MD, Bulte DP, Alfonsi J (2003) BOLD magnetic
resonance imaging of skeletal muscle. Semin Musculoskelet
Radiol 7(4):307–315
11. Toussaint JF, Kwong KK, Mkparu FO, Weisskoff RM, LaRaia
PJ, Kantor HL (1996) Perfusion changes in human skeletal
muscle during reactive hyperemia measured by echo-planar
imaging. Magn Reson Med 35(1):62–69
12. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR (1994)
Microscopic susceptibility variation and transverse relaxation:
theory and experiment. Magn Reson Med 31(6):601–610
13. Lebon VB-SC, Bloch G, Leroy-Willig A, Carlier PG (1998)
Evidence of muscle BOLD effect revealed by simultaneous
interleaved gradient-echo NMRI and myoglobin NMRS during
leg ischemia. Magn Reson Med 40:551–558
14. Ledermann HP, Heidecker HG, Schulte AC, Thalhammer C,
Aschwanden M, Jaeger KA, Scheffler K, Bilecen D (2006) Calf
muscles imaged at BOLD MR: correlation with TcPO2 and
flowmetry measurements during ischemia and reactive hyper-
emia–initial experience. Radiology 241(2):477–484
15. Sanchez OA, Copenhaver EA, Elder CP, Damon BM (2010)
Absence of a significant extravascular contribution to the
skeletal muscle BOLD effect at 3 T. Magn Reson Med 64(2):
527–535
16. Schulte AC, Speck O, Oesterle C, Hennig J (2001) Separation
and quantification of perfusion and BOLD effects by simulta-
neous acquisition of functional I(0)- and T2(*)-parameter maps.
Magn Reson Med 45(5):811–816
17. Meyer RA, Towse TF, Reid RW, Jayaraman RC, Wiseman RW,
McCully KK (2004) BOLD MRI mapping of transient hyperemia
in skeletal muscle after single contractions. NMR Biomed 17(6):
392–398
18. Hennig JSK, Schreiber A (2000) Time resolved observation of
BOLD effect in muscle during isometric exercise. Proc Int Soc
Magn Reson Med 8:122
19. Jordan B, Kimpalou J, Beghein N, Dessy C, Feron O, Gallez B
(2004) Contribution of oxygenation to BOLD contrast in exer-
cising muscle. Magn Reson Med 52(2):391–396
20. Damon BM, Hornberger JL, Wadington MC, Lansdown DA,
Kent-Braun JA (2007) Dual gradient-echo MRI of post-contrac-
tion changes in skeletal muscle blood volume and oxygenation.
Magn Reson Med 57(4):670–679
21. Carlier PG, Bertoldi D, Baligand C, Wary C, Fromes Y (2006)
Muscle blood flow and oxygenation measured by NMR imaging
and spectroscopy. NMR Biomed 19(7):954–967
22. Wigmore DM, Damon BM, Pober DM, Kent-Braun JA (2004)
MRI measures of perfusion-related changes in human skeletal
muscle during progressive contractions. J Appl Physiol 97(6):
2385–2394
23. Duteil S, Wary C, Raynaud JS, Lebon V, Lesage D, Leroy-Willig
A, Carlier PG (2006) Influence of vascular filling and perfusion
on BOLD contrast during reactive hyperemia in human skeletal
muscle. Magn Reson Med 55(2):450–454
24. Towse TF, Slade JM, Ambrose JA, Delano MC, Meyer RA
(2011) Quantitative analysis of the post-contractile blood-oxy-
genation-level-dependent (BOLD) effect in skeletal muscle.
J Appl Physiol 111(1):27–39
25. Towse TF, Slade JM, Meyer RA (2005) Effect of physical
activity on MRI-measured blood oxygen level-dependent tran-
sients in skeletal muscle after brief contractions. J Appl Physiol
99(2):715–722
26. Utz W, Jordan J, Niendorf T, Stoffels M, Luft FC, Dietz R,
Friedrich MG (2005) Blood oxygen level-dependent MRI of
tissue oxygenation: relation to endothelium-dependent and
endothelium-independent blood flow changes. Arterioscler
Thromb Vasc Biol 25(7):1408–1413
27. Damon BM, Gore JC (2005) Physiological basis of muscle
functional MRI: predictions using a computer model. J Appl
Physiol 98(1):264–273
28. Wilkie DR, Dawson MJ, Edwards RH, Gordon RE, Shaw D
(1984) 31P NMR studies of resting muscle in normal human
subjects. Adv Exp Med Biol 170:333–347
Magn Reson Mater Phy (2012) 25:251–261 259
123
29. Lebon VC, Carlier PG, Brillault-Salvat C, Bloch G, Leroy-Willig
A (1998) Anisotropy of the BOLD effect in the skeletal muscle.
Proceedings ISMRM Sydney: 1424
30. Schulte AC, Aschwanden M, Bilecen D (2008) Calf muscles at
blood oxygen level-dependent MR imaging: aging effects at
postocclusive reactive hyperemia. Radiology 247(2):482–489
31. Slade JM, Towse TF, Gossain VV, Meyer RA (2011) Peripheral
microvascular response to muscle contraction is unaltered by early
diabetes, but decreases with age. J Appl Physiol 111(5):1361–1371
32. Bulte DP, Alfonsi J, Bells S, Noseworthy MD (2006) Vaso-
modulation of skeletal muscle BOLD signal. J Magn Reson
Imaging 24(4):886–890
33. Ledermann HP, Schulte AC, Heidecker HG, Aschwanden M,
Ja¨ger KA, Scheffler K, Steinbrich W, Bilecen D (2006) Blood
oxygenation level-dependent magnetic resonance Imaging of the
skeletal muscle in patients with peripheral arterial occlusive
disease. Circulation 113(25):2929–2935
34. Noseworthy MD, Davis AD, Elzibak AH (2010) Advanced MR
imaging techniques for skeletal muscle evaluation. Semin Mus-
culoskelet Radiol 14(2):257–268
35. Gold GE (2003) Dynamic and functional imaging of the mus-
culoskeletal system. Semin Musculoskelet Radiol 7(4):245–248
36. Kos S, Klarhofer M, Aschwanden M, Scheffler K, Jacob AL,
Bilecen D (2009) Simultaneous dynamic blood oxygen level-
dependent magnetic resonance imaging of foot and calf muscles:
aging effects at ischemia and postocclusive hyperemia in healthy
volunteers. Invest Radiol 44(11):741–747
37. Lebon V, Carlier PG, Brillault-Salvat C, Leroy-Willig A (1998)
Simultaneous measurement of perfusion and oxygenation chan-
ges using a multiple gradient-echo sequence: application to
human muscle study. Magn Reson Imaging 16(7):721–729
38. Potthast S, Schulte A, Kos S, Aschwanden M, Bilecen D (2009)
Blood oxygenation level-dependent MRI of the skeletal muscle
during ischemia in patients with peripheral arterial occlusive
disease. Rofo 181(12):1157–1161
39. Andreisek G, White LM, Sussman MS, Langer DL, Patel C, Su
JW, Haider MA, Stainsby JA (2009) T2*-weighted and arterial
spin labeling MRI of calf muscles in healthy volunteers and
patients with chronic exertional compartment syndrome: pre-
liminary experience. AJR Am J Roentgenol 193(4):W327–W333
40. Huegli RW, Schulte AC, Aschwanden M, Thalhammer C, Kos S,
Jacob AL, Bilecen D (2009) Effects of percutaneous transluminal
angioplasty on muscle BOLD-MRI in patients with peripheral
arterial occlusive disease: preliminary results. Eur Radiol
19(2):509–515
41. Howseman AM, Bowtell RW (1999) Functional magnetic reso-
nance imaging: imaging techniques and contrast mechanisms.
Philos Trans R Soc Lond B Biol Sci 354(1387):1179–1194
42. Block KT, Frahm J (2005) Spiral imaging: a critical appraisal.
J Magn Reson Imaging 21(6):657–668
43. Speck O, Hennig J (1998) Functional imaging by I0- and T2*-
parameter mapping using multi-image EPI. Magn Reson Med
40(2):243–248
44. Diehm C, Kareem S, Lawall H (2004) Epidemiology of periph-
eral arterial disease. Vasa 33(4):183–189
45. Selvin E, Erlinger TP (2004) Prevalence of and risk factors for
peripheral arterial disease in the United States: results from the
National Health and Nutrition Examination Survey, 1999–2000.
Circulation 110(6):738–743
46. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FG (2007) Inter-Society consensus for the management
of peripheral arterial disease (TASC II). J Vasc Surg 45 Suppl
S:S5–67
47. Clyne CA, Mears H, Weller RO, O’Donnell TF (1985) Calf
muscle adaptation to peripheral vascular disease. Cardiovasc Res
19(8):507–512
48. Henriksson J, Nygaard E, Andersson J, Eklof B (1980) Enzyme
activities, fibre types and capillarization in calf muscles of
patients with intermittent claudication. Scand J Clin Lab Invest
40(4):361–369
49. Regensteiner JG, Wolfel EE, Brass EP, Carry MR, Ringel SP,
Hargarten ME, Stamm ER, Hiatt WR (1993) Chronic changes in
skeletal muscle histology and function in peripheral arterial dis-
ease. Circulation 87(2):413–421
50. Prince MR (1998) Peripheral vascular MR angiography: the time
has come. Radiology 206(3):592–593
51. Rofsky NM, Adelman MA (2000) MR angiography in the eval-
uation of atherosclerotic peripheral vascular disease. Radiology
214(2):325–338
52. Begelman SM, Jaff MR (2006) Noninvasive diagnostic strategies
for peripheral arterial disease. Cleve Clin J Med 73(Suppl
4):S22–S29
53. van Langen H, van Gurp J, Rubbens L (2009) Interobserver
variability of ankle-brachial index measurements at rest and post
exercise in patients with intermittent claudication. Vasc Med
14(3):221–226
54. Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V,
Olin JW (2006) Limitation of the resting ankle-brachial index in
symptomatic patients with peripheral arterial disease. Vasc Med
11(1):29–33
55. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT (2002) Exercise
training for claudication. N Engl J Med 347(24):1941–1951
56. Prielmeier F, Nagatomo Y, Frahm J (1994) Cerebral blood oxy-
genation in rat brain during hypoxic hypoxia. Quantitative MRI
of effective transverse relaxation rates. Magn Reson Med
31(6):678–681
57. Prielmeier F, Merboldt KD, Hanicke W, Frahm J (1993) Dynamic
high-resolution MR imaging of brain deoxygenation during
transient anoxia in the anesthetized rat. J Cereb Blood Flow
Metab 13(5):889–894
58. Villringer A (1997) Understanding functional neuroimaging
methods based on neurovascular coupling. Adv Exp Med Biol
413:177–193
59. Barrett T, Brechbiel M, Bernardo M, Choyke PL (2007) MRI of
tumor angiogenesis. J Magn Reson Imaging 26(2):235–249
60. Baudelet C, Cron GO, Gallez B (2006) Determination of the
maturity and functionality of tumor vasculature by MRI: corre-
lation between BOLD-MRI and DCE-MRI using P792 in
experimental fibrosarcoma tumors. Magn Reson Med
56(5):1041–1049
61. Hickey NC, Hudlicka O, Simms MH (1992) Claudication induces
systemic capillary endothelial swelling. Eur J Vasc Surg
6(1):36–40
62. Dawson JM, Hudlicka O (1990) Changes in the microcirculation
in slow and fast skeletal muscles with long term limitations of
blood supply. Cardiovasc Res 24(5):390–395
63. McGuigan MR, Bronks R, Newton RU, Sharman MJ, Graham
JC, Cody DV, Kraemer WJ (2001) Muscle fiber characteristics in
patients with peripheral arterial disease. Med Sci Sports Exerc
33(12):2016–2021
64. Versluis B, Backes WH, van Eupen MG, Jaspers K, Nelemans PJ,
Rouwet EV, Teijink JA, Mali WP, Schurink GW, Wildberger JE,
Leiner T (2011) Magnetic resonance imaging in peripheral arte-
rial disease: reproducibility of the assessment of morphological
and functional vascular status. Invest Radiol 46(1):11–24
65. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Hal-
ligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D,
Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ (2005)
Endothelial function and dysfunction. Part I: methodological
issues for assessment in the different vascular beds: a statement
by the working group on endothelin and endothelial factors of the
European Society of hypertension. J Hypertens 23(1):7–17
260 Magn Reson Mater Phy (2012) 25:251–261
123
66. Lutz AM, Weishaupt D, Amann-Vesti BR, Pfammatter T, Goe-
pfert K, Marincek B, Nanz D (2004) Assessment of skeletal
muscle perfusion by contrast medium first-pass magnetic reso-
nance imaging: technical feasibility and preliminary experience
in healthy volunteers. J Magn Reson Imaging 20(1):111–121
67. Mohajer K, Zhang H, Gurell D, Ersoy H, Ho B, Kent KC, Prince
MR (2006) Superficial femoral artery occlusive disease severity
correlates with MR cine phase-contrast flow measurements.
J Magn Reson Imaging 23(3):355–360
68. Galbraith SM, Lodge MA, Taylor NJ, Rustin GJ, Bentzen S,
Stirling JJ, Padhani AR (2002) Reproducibility of dynamic con-
trast-enhanced MRI in human muscle and tumours: comparison
of quantitative and semi-quantitative analysis. NMR Biomed
15(2):132–142
69. Hanna GP, Fujise K, Kjellgren O, Feld S, Fife C, Schroth G,
Clanton T, Anderson V, Smalling RW (1997) Infrapopliteal
transcatheter interventions for limb salvage in diabetic patients:
importance of aggressive interventional approach and role of
transcutaneous oximetry. J Am Coll Cardiol 30(3):664–669
70. Wagner HJ, Schmitz R, Alfke H, Klose KJ (2003) Influence of
percutaneous transluminal angioplasty on transcutaneous oxygen
pressure in patients with peripheral arterial occlusive disease.
Radiology 226(3):791–797
71. Markkanen JE, Rissanen TT, Kivela A, Yla-Herttuala S (2005)
Growth factor-induced therapeutic angiogenesis and arteriogen-
esis in the heart gene therapy. Cardiovasc Res 65(3):656–664
72. Tammela T, Enholm B, Alitalo K, Paavonen K (2005) The
biology of vascular endothelial growth factors. Cardiovasc Res
65(3):550–563
73. Aghi M, Chiocca EA (2005) Contribution of bone marrow-
derived cells to blood vessels in ischemic tissues and tumors. Mol
Ther 12(6):994–1005
74. Wahlberg E (2003) Angiogenesis and arteriogenesis in limb
ischemia. J Vasc Surg 38(1):198–203
75. Fraipont MJ, Adamson GJ (2003) Chronic exertional compart-
ment syndrome. J Am Acad Orthop Surg 11(4):268–276
76. Verleisdonk EJ, van Gils A, van der Werken C (2001) The
diagnostic value of MRI scans for the diagnosis of chronic
exertional compartment syndrome of the lower leg. Skeletal
Radiol 30(6):321–325
77. Eskelin MK, Lotjonen JM, Mantysaari MJ (1998) Chronic
exertional compartment syndrome: MR imaging at 0.1 T compared
with tissue pressure measurement. Radiology 206(2):333–337
78. Litwiller DV, Amrami KK, Dahm DL, Smith J, Laskowski ER,
Stuart MJ, Felmlee JP (2007) Chronic exertional compartment
syndrome of the lower extremities: improved screening using a
novel dual birdcage coil and in-scanner exercise protocol. Skel-
etal Radiol 36(11):1067–1075
79. Davies AD, Noseworthy MD (2011) Fourier analysis of muscle
BOLD data after exercise. Int Soc Magn Reson Med 19:1163
80. Golster H, Hyllienmark L, Ledin T, Ludvigsson J, Sjoberg F
(2005) Impaired microvascular function related to poor metabolic
control in young patients with diabetes. Clin Physiol Funct
Imaging 25(2):100–105
81. Cesarone MR, De Sanctis MT, Incandela L, Belcaro G, Griffin
M, Cacchio M (2001) Methods of evaluation and quantification
of microangiopathy in high perfusion microangiopathy (chronic
venous insufficiency and diabetic microangiopathy). Angiology
52(Suppl 2):S3–S7
82. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park
JY, King GL, LoGerfo FW, Horton ES, Veves A (1999) Micro-
vascular and macrovascular reactivity is reduced in subjects at
risk for type 2 diabetes. Diabetes 48(9):1856–1862
83. Fathi R, Marwick TH (2001) Noninvasive tests of vascular
function and structure: why and how to perform them. Am Heart
J 141(5):694–703
84. McCully KK, Posner JD (1995) The application of blood flow
measurements to the study of aging muscle. J Gerontol A Biol Sci
Med Sci 50:130–136
85. Sanchez OA, Copenhaver EA, Chance MA, Fowler MJ, Towse
TF, Kent-Braun JA, Damon BM (2011) Postmaximal contraction
blood volume responses are blunted in obese and type 2 diabetic
subjects in a muscle-specific manner. Am J Physiol Heart Circ
Physiol 301(2):H418–H427
Magn Reson Mater Phy (2012) 25:251–261 261
123
